First, for patients after liver cancer surgery, whether CDK4 can be used as a tumor marker for related exploration, early warning of liver cancer metastasis, second liver cancer surgery, or early treatment for new metastatic lesions. This evidence concerns the gene CDK4 and neoplasm.